Viking Therapeutics, Inc. Earnings Per Share (Basic)
Viking Therapeutics, Inc. (VKTX) reported Earnings Per Share (Basic) of -$1.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-29
- Viking Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.10.
- Viking Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.37.
- Viking Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.81.
- Viking Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.58.
- Viking Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$3.19.
- Viking Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$1.01.
- Viking Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$0.91.
- Viking Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$0.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.10 10-Q · filed 2026-07-29 | -$2.47 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | -$1.37 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$3.19 10-K · filed 2026-02-11 | |||
| 2025-09-30 | -$0.81 10-Q · filed 2025-10-23 | -$1.80 10-Q · filed 2025-10-23 | ||
| 2025-06-30 | -$0.58 10-Q · filed 2026-07-29 | -$0.99 10-Q · filed 2026-07-29 | ||
| 2025-03-31 | -$0.41 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$1.01 10-K · filed 2026-02-11 | |||
| 2024-09-30 | -$0.22 10-Q · filed 2025-10-23 | -$0.69 10-Q · filed 2025-10-23 | ||
| 2024-06-30 | -$0.20 10-Q · filed 2025-07-23 | -$0.46 10-Q · filed 2025-07-23 | ||
| 2024-03-31 | -$0.26 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | -$0.91 10-K · filed 2026-02-11 | |||
| 2023-09-30 | -$0.23 10-Q · filed 2024-10-23 | -$0.66 10-Q · filed 2024-10-23 | ||
| 2023-06-30 | -$0.19 10-Q · filed 2024-07-24 | -$0.44 10-Q · filed 2024-07-24 | ||
| 2023-03-31 | -$0.25 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | -$0.90 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$0.21 10-Q · filed 2023-10-25 | -$0.64 10-Q · filed 2023-10-25 | ||
| 2022-06-30 | -$0.23 10-Q · filed 2023-07-26 | -$0.43 10-Q · filed 2023-07-26 | ||
| 2022-03-31 | -$0.21 10-Q · filed 2023-04-26 | |||
| 2021-12-31 | -$0.71 10-K · filed 2024-02-07 | |||
| 2021-09-30 | -$0.17 10-Q · filed 2022-10-26 | -$0.55 10-Q · filed 2022-10-26 | ||
| 2021-06-30 | -$0.20 10-Q · filed 2022-07-27 | -$0.38 10-Q · filed 2022-07-27 | ||
| 2019-03-31 | -$0.07 10-Q · filed 2019-05-02 | |||
| 2018-03-31 | -$0.08 10-Q · filed 2019-05-02 | |||
| 2017-03-31 | -$0.23 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |